Morphine Mimics the Cardioprotective Effect of Ischemic Preconditioning via a Glibenclamide-Sensitive Mechanism in the Rat Heart

Circulation Research

Volumn 78, Issue 6, 1996, Pages 1100-1104

  Schultz, Jo El J ^a   Hsu, Anna K ^a   Gross, Garrett J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

ATP sensitive K+ channels; Myocardial infarction; Naloxone; Opioid receptors

Indexed keywords

GLIBENCLAMIDE; MORPHINE; NALOXONE; OPIATE AGONIST; OPIATE RECEPTOR; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; THIOBUTABARBITAL; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; DRUG MECHANISM; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEMODYNAMICS; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; GLYBURIDE; HEART; HEMODYNAMIC PROCESSES; MALE; MORPHINE; MYOCARDIAL ISCHEMIA; NALOXONE; POTASSIUM CHANNELS; RATS; RATS, WISTAR; RECEPTORS, OPIOID;

EID: 0029886874     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.78.6.1100     Document Type: Article

References (31)

1. Mayfield KP, D'Alecy LG. Delta-1 opioid agonist acutely increases hypoxic tolerance. J Pharmacol Exp Ther. 1994;268:74-77.
2. 5]-enkephalin). J Thorac Cardiovasc Surg. 1994;107:964-967.
3. Schultz JJ, Rose E, Yao Z, Gross GJ. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol. 1995;268:H2157-H2161.
4. Chien GL, Tang Y, Van Winkle DM. Stereospecific blockade of myocardial ischemic preconditioning by naloxone. Circulation. 1995;92(suppl 8):I-389. Abstract.
5. North RA. Opioid actions on membrane ion channels. In: Herz A, ed. Handbook of Pharmacology: Opioids I. New York, NY: Spring-er-Verlag; 1993:774-797.
6. North RA, Williams JT, Surprenant A, Christie MJ. μ and δ receptors belong to a family of receptors that are coupled to potassium channels. Proc Natl Acad Sci U S A. 1987;84:5487-5491.
7. + channel. J Biol Chem. 1994;269:7839-7842.
8. Ocana M, Del Pozo E, Barrios M, Robles LI, Baeyens JM. An ATP-dependent potassium channel blocker antagonizes morphine analgesia. Eur J Pharmacol. 1990;186:377-378.
9. + channel-acting drugs. Br J Pharmacol. 1995;114:1296-1302.
10. Raffa RB, Martinez RP. The "glibenclamide-shift' of centrally-acting antinociceptive agents in mice. Brain Res. 1995;67:277-282.
11. Welch SP, Dunlow LD. Antinociception activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action? J Pharmacol Exp Ther. 1993;267:390-399.
12. + channel openers inhibit morphine withdrawal. Eur J Pharmacol. 1994;251:113-115.
13. + channels. Am J Physiol. 1995;269:H997-H1002.
14. Klein HH, Puschmann S, Schaper J, Schaper W. The mechanism of the tetrazolium reaction in identifying myocardial infarction. Virchows Arch. 1981;393:287-297.
15. Holaday JW. Cardiovascular effects of endogenous opiate systems. Annu Rev Pharmacol Toxicol. 1983;23:541-594.
16. Zhan ZY, Lee AYS, Wong TM. Naloxone blocks the cardiac effects of myocardial ischemia and reperfusion in the rat isolated heart. Clin Exp Pharmacol Physiol. 1985;12:373-378.
17. Liang C, Imai N, Stone CK, Woolf PD, Kawashima S, Tuttle RR. The role of endogenous opioids in congestive heart failure: effects of nalmefene on systemic and regional hemodynamics in dogs. Circulation. 1987;75:443-451.
18. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
19. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res. 1992;70: 223-233.
20. Toombs CF, Moore TL, Shebuski RJ. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide. Cardiovasc Res. 1993;27:617-622.
21. ATP channel. Am J Physiol. 1994;266:H829-H839.
22. + channel blocker. Circulation. 1994;90:700-705.
23. Schulz R, Rose J, Heusch G. Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine. Am J Physiol. 1994;267:H1341-H1352.
24. Liu Y, Downey JM. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol. 1992;263:H1107-H1112.
25. Grover GJ, Dzwonczyk S, Parham CS, Sleph PG. The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs. Cardiovasc Drugs Ther. 1990;4:465-474.
26. Fralix TA, Steenbergen C, London RE, Murphy E. Glibenclamide does not abolish the protective effect of preconditioning on stunning in the isolated perfused rat heart. Cardiovasc Res. 1993;27:630-637.
27. 1B-adrenoceptors, pertussis toxin-sensitive G proteins, and protein kinase C. Circulation. 1995;9:2259-2265.
28. Asimakis GK, Inners-McBride K, Conti VR, Yang C. Transient β adrenergic stimulation can precondition the rat heart against post-ischaemic contractile dysfunction. Cardiovasc Res. 1994;28:1726-1734.
29. Richard V, Blanc R, Kaeffer N, Tron C, Thuillez C. Myocardial and coronary endothelial protective effects of acetylcholine after myocardial ischaemia and reperfusion in rats: role of nitric oxide. Br J Pharmacol. 1995;115:1532-1538.
30. Martin WR. Pharmacology of opioids. Pharmacol Rev. 1983;35:283-323.
31. Perchenet L, Kreher P. Mechanical and electrophysiological effects of preconditioning in isolated ischemic/reperfused rat hearts. J Cardiovasc Pharmacol. 1995;26:831-840.